Labshake search
Citations for Tocris :
1 - 50 of 239 citations for H D Glu amc oh since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... MNI-Glu (Tocris) was prepared by dissolution into ACSF at 30 mM ...
-
bioRxiv - Neuroscience 2021Quote: ... MNI Caged Glu (Tocris, 4 mM), APV (Sigma ...
-
bioRxiv - Neuroscience 2023Quote: ... 3 mM L-glutamate (Glu, #0218, Tocris, UK) and 0.1 mM cyclothiazide (CTZ ...
-
bioRxiv - Neuroscience 2023Quote: ... 8-OH-DPAT (Tocris) was first dissolved in 100% DMSO and then diluted in a vehicle of 10% DMSO and 0.9% saline ...
-
bioRxiv - Neuroscience 2021Quote: ... we used ruthenium-bipyridine-trimethylphosphine-caged glutamate (RuBi-glu, Tocris) (Fino et al. ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 µM 4-OH-TMX (Tocris Bioscience) was added to sustain knockout efficiency ...
-
bioRxiv - Neuroscience 2024Quote: ... For glutamate uncaging with 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNNI-glu, Tocris, MN, USA), 2.5 mM MNI-glu was diluted in freshly prepared recording ACSF and applied to the bath through a circulating pump ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-HT1A-R agonist 8-OH-DPAT or antagonist NAN-190 (NAN) were from Tocris (UK). Competition was performed at concentration between 10−11 to 10−5 M ...
-
bioRxiv - Neuroscience 2020Quote: ... and H-89 dihydrochloride (H-89, 10 μM, Tocris) were used in acute slice experiments ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... The noncompetitive AMPAR antagonist GYKI 52466 [4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-benzenamine dihydrochloride] was purchased from Tocris (R&D Systems, Minneapolis, MN) and dissolved in a vehicle of 0.9% NaCl for intraperitoneal (IP ...
-
bioRxiv - Immunology 2021Quote: In vitro tamoxifen was given as 4-hydroxytamoxifen (4-OH-Tamoxifen or OHT) (TOCRIS, Cat no. 3412) solubilized in DMSO (Life Technologies ...
-
bioRxiv - Neuroscience 2024Quote: ... D-AP5/D-APV (HelloBio/Tocris, HB0225/0106), Ifenprodil (HelloBio ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (Tocris) at 50 μM ...
-
bioRxiv - Cell Biology 2021Quote: ... Actinomycin D (Tocris) was added to a final concentration of 100 μg/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (Tocris) and NiCl2 (Sigma ...
-
bioRxiv - Genomics 2022Quote: ... and 100μM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) overnight to reduce endogenous neuronal activity prior to stimulation ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Biochemistry 2024Quote: ... 25 μM d-(−)-2-amino-5-phosphonovaleric acid (D-AP5, Tocris), and 100 μM picrotoxin (Nacalai Tesque ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50µM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris 0106). Neurons were voltage clamped at -70mV ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 mM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris) to block AMPA and NMDA receptors ...
-
bioRxiv - Cell Biology 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50 µM, Tocris), 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX 20 µM ...
-
bioRxiv - Genetics 2024Quote: ... D-2-amino-5-phosphonovalerate (D-AP5; 100 µM, Tocris 0106), bicuculline (20 µM ...
-
bioRxiv - Immunology 2023Quote: ... TC-H 106 (Tocris, UK), bufexamac (FUJIFILM ...
-
bioRxiv - Physiology 2022Quote: ... H-89 (Tocris Bioscience #2910), AT13148 (Selleck #S7563 ...
-
bioRxiv - Cell Biology 2022Quote: ... H-89 dihydrochloride (10μM, Tocris), NFκB nuclear translocation inhibitor (100μg/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (50μM, Tocris) or DL-AP5 (25μM ...
-
bioRxiv - Neuroscience 2022Quote: D-AP5 (Tocris, USA) was suspended in water as 50 mM stock solution ...
-
bioRxiv - Neuroscience 2024Quote: ... D-AP-550μM (Tocris), and TTX 1 μM (Tocris ...
-
bioRxiv - Neuroscience 2022Quote: ... D-AP5 (#0106, Tocris), PPADS (ab12009 ...
-
bioRxiv - Immunology 2024Quote: ... The HCA3R agonists IBC 293 (1-(1-Methylethyl)-1H-benzotriazole-5-carboxylic acid) and 3-hydroxy-octanoic acid (3-OH-C8) were from Tocris (Bristol, UK) and Cayman Chemical (Michigan ...
-
bioRxiv - Cell Biology 2022Quote: Cells were treated with 0.05 µg/ml Actinomycin D (Act D) (1229, Tocris) dissolved in DMSO in a complete medium for 0.5 or 2 h at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... D-2-amino-5-phosphonopentanoate (D-AP5, Tocris, Ellisville, MO, Cat. No. 0106 ), and Dizocilpine ((+)-MK801 ...
-
bioRxiv - Cell Biology 2024Quote: ... DM+D+P was composed of DM+D including PD0325901 (0.1 µM, Tocris #4192). The concentration of dissolvent was equal in all medium conditions ...
-
bioRxiv - Neuroscience 2024Quote: ... evaluation of D-amphetamine-induced hyperlocomotion (D-amphetamine sulfate, 3 mg/kg; TOCRIS 2813), were both evaluated in the open field as described elsewhere (Sancho-Balsells et al. ...
-
bioRxiv - Neuroscience 2024Quote: ... and 30 μm d-2-amino-5-phosphonovalerate (d-AP5) (NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... 40 D-APV (Tocris Bioscience), and 10 bicuculline (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2021Quote: ... cytochalasin D (100 nM; Tocris), Latrunculin A (0.3 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... D-APV (25 µM, Tocris), mibefradil (10 µM ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 µM D-APV (Tocris), 10 µM CNQX ...
-
bioRxiv - Neuroscience 2020Quote: ... D-APV (25 μM, Tocris), gabazine (GBZ ...
-
bioRxiv - Neuroscience 2022Quote: ... D-AP5 (50 µM, Tocris). In the DREADD experiments ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50µM D-AP5 (Tocris) were included in the bath for mIPSC and GABA puffing ...
-
bioRxiv - Neuroscience 2021Quote: ... and 50µM D-AP5 (Tocris) were included in the bath for evoked IPSC recordings ...